Cargando…
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
We have previously identified serum miR-483-5p as a preoperative diagnosis and prognosis biomarker for adrenocortical cancer (ACC). Here, we aimed to determine whether circulating miR-483-5p levels measured 3 months post-operatively distinguished patients with good prognosis (no recurrence for at le...
Autores principales: | Oreglia, Maurine, Sbiera, Silviu, Fassnacht, Martin, Guyon, Laurent, Denis, Josiane, Cristante, Justine, Chabre, Olivier, Cherradi, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140036/ https://www.ncbi.nlm.nih.gov/pubmed/32204444 http://dx.doi.org/10.3390/cancers12030724 |
Ejemplares similares
-
MicroRNA Therapeutics in Cancer: Current Advances and Challenges
por: Reda El Sayed, Soha, et al.
Publicado: (2021) -
Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
por: Sbiera, Iuliu, et al.
Publicado: (2021) -
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
por: Landwehr, Laura-Sophie, et al.
Publicado: (2020) -
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022) -
Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications
por: Sbiera, Iuliu, et al.
Publicado: (2021)